The role of mutational profiling in MM, which shows a very heterogeneous molecular landscape, remains to be determined in future studies, but mutational analysis of TP53 is recommended for relapsed MM [40, 51, 59]. The gene discussed is TP53; the disease is Miyoshi myopathy.